Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    NanoLogix Improves Live-Cell Detection Times for Biothreat Agents

    By Global Biodefense StaffJune 20, 2012
    Share
    Facebook LinkedIn Reddit Email

    In collaboration with University of Texas Health Science Center – Houston (UTHSC-Houston), NanoLogix is developing a multi-well microplate reader variant of the company’s BioNanoFilter (BNF) live cell diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results similar to the company’s standard BNF technology.

    NanoLogix technology can detect whether or not a microorganism found in the sample is alive, and therefore a viable health threat. This distinction between live and dead cells is considered a crucial requirement in the identification of pathogenic microorganisms. It is the reason many laboratories continue to insist on live-cell results, despite the slightly longer wait over methods such a Polymerase Chain Reaction (PCR) which only detect the presence of the organism in the sample.

    Research from a recently completed clinical study using NanoLogix technology was presented last week at the General Meeting of American Society for Microbiology by Dr. Jonathan Faro of UTHSC-Houston.  The study, focused on detection, identification, and determination of antibiotic sensitivity of Group B Streptococcus (GBS) during pregnancy, demonstrated how NanoLogix diagnostics consistently provided quality results in a 4 to 6 hour window, dramatically shorter than standard culturing times of 48 to 72 hours.  The data is currently being formatted for submission to the US FDA for acceptance as a non-invasive diagnostic technology.

    “We are thrilled to be dramatically cutting bacterial detection times from days to hours for many pathogens,” said NanoLogix CEO Bret Barnhizer. “Specifically, we have reduced wait times for TB (tuberculosis) from weeks to days, while protozoa detection times for Cryptosporidium, which is responsible for over 50 percent of waterborne illnesses, have been cut from weeks to hours. At the same time, we have been able to accomplish these results with improved quality of detection.”

    Conventional tests for anthrax can take 24 hours, and more than 48 hours for bubonic plague. The NanoLogix BNF technology cuts those times to less than an hour, providing critical information more rapidly to decision makers during a public health emergency.

    Anthrax Nanotech
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFunding Award for a Combined Smallpox-Marburg Vaccine
    Next Article CBER Seeks Small Businesses in Support of TB Vaccine Research

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023

    Field Detection of Botulinum Neurotoxin with Acoustic Wave Sensors

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.